Form 4: Doximity Director Kira Scherer Wampler Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Kira Scherer Wampler, a director at Doximity, Inc., exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 1, 2025, Kira Scherer Wampler, a director of Doximity, Inc., executed a stock option to acquire 2,000 shares of Class A Common Stock.
- Wampler also converted 2,000 shares of Class B Common Stock into Class A Common Stock.
- She sold 1,589 shares of Class A Common Stock at a weighted average price of $56.7429 and 411 shares at a weighted average price of $57.6364.
- These sales were conducted under a Rule 10b5-1 trading plan adopted on November 12, 2024.
- Following these transactions, Wampler directly owns 16,618 shares of Class A Common Stock and 476,700 shares of Class B Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of a 10b5-1 trading plan allows insiders to sell shares over time while avoiding concerns about trading on non-public information.
Comparison to Industry Standards
- Monitoring insider transactions is standard practice for investors to gauge management's sentiment and potential future performance.
- Companies like Teladoc and Veeva Systems, which operate in related healthcare technology sectors, also have similar insider transaction disclosures.
- The use of Rule 10b5-1 trading plans is a common and accepted method for corporate insiders to manage their stock holdings.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider sentiment.
- Employees are unlikely to be significantly affected by these transactions.
Key Dates
| Date | Description |
|---|---|
| 2020-03-27 | Stock option vesting began in 36 equal monthly installments after this date. |
| 2020-06-10 | Stock option was granted. |
| 2024-11-12 | Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 2025-05-01 | Earliest transaction date; stock option exercise and stock sales occurred. |
| 2025-05-02 | Date of signature for the Form 4 filing. |
| 2030-06-09 | Expiration date of the stock option. |
Keywords
Form 4, Doximity, DOCS, Insider Trading, Stock Option, Rule 10b5-1, Kira Scherer Wampler, Class A Common Stock, Class B Common Stock, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.